Invasive Pneumococcal Disease, Protection Against
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Invasive Pneumococcal Disease, Protection Against trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Invasive Pneumococcal Disease, Protection Against trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Before the introduction of pneumonia vaccines in 2000, between 700,000 - 1 million children died each year as a result of infection with the bacteria Streptococ…
This study is assessing if a reduced dosing schedule (1+1) of the 13-valent pneumococcal conjugate vaccine (PCV13) is non-inferior to the currently used schedul…
This is a multicentre prospective audit to determine the incidence of immunodeficiency in children with IPD. Aims and/or research question of the project 1. T…
The objective of this study is to document the residual burden of acute upper respiratory infections (AURIs), acute lower respiratory infections (ALRIs), otitis…